122 related articles for article (PubMed ID: 10733507)
1. Retroviral transfer of the hENT2 nucleoside transporter cDNA confers broad-spectrum antifolate resistance in murine bone marrow cells.
Patel DH; Allay JA; Belt JA; Sorrentino BP
Blood; 2000 Apr; 95(7):2356-63. PubMed ID: 10733507
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors.
Allay JA; Spencer HT; Wilkinson SL; Belt JA; Blakley RL; Sorrentino BP
Blood; 1997 Nov; 90(9):3546-54. PubMed ID: 9345038
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
Allay JA; Galipeau J; Blakley RL; Sorrentino BP
Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
[TBL] [Abstract][Full Text] [Related]
4. In vivo selection of antifolate-resistant transgenic hematopoietic stem cells in a murine bone marrow transplant model.
Warlick CA; Diers MD; Wagner JE; McIvor RS
J Pharmacol Exp Ther; 2002 Jan; 300(1):50-6. PubMed ID: 11752096
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
Crawford CR; Patel DH; Naeve C; Belt JA
J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
[TBL] [Abstract][Full Text] [Related]
7. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
[TBL] [Abstract][Full Text] [Related]
10. The murine-reduced folate carrier gene can act as a selectable marker and a suicide gene in hematopoietic cells in vivo.
Liu S; Song L; Bevins R; Birhiray O; Moscow JA
Hum Gene Ther; 2002 Sep; 13(14):1777-82. PubMed ID: 12396629
[TBL] [Abstract][Full Text] [Related]
11. Effect of nucleoside transport inhibitors on thymidine salvage and the toxicity of nucleoside analogs in mouse bone marrow granulocyte-macrophage progenitor cells.
Marina NM; Belt JA
Cancer Commun; 1991; 3(12):367-72. PubMed ID: 16296002
[TBL] [Abstract][Full Text] [Related]
12. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs.
Galipeau J; Benaim E; Spencer HT; Blakley RL; Sorrentino BP
Hum Gene Ther; 1997 Oct; 8(15):1773-83. PubMed ID: 9358027
[TBL] [Abstract][Full Text] [Related]
13. Retroviral expression of Escherichia coli thymidylate synthase cDNA confers high-level antifolate resistance to hematopoietic cells.
Shaw D; Berger FG; Spencer HT
Hum Gene Ther; 2001 Jan; 12(1):51-9. PubMed ID: 11177542
[TBL] [Abstract][Full Text] [Related]
14. A gene transfer strategy for making bone marrow cells resistant to trimetrexate.
Spencer HT; Sleep SE; Rehg JE; Blakley RL; Sorrentino BP
Blood; 1996 Mar; 87(6):2579-87. PubMed ID: 8630426
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
[TBL] [Abstract][Full Text] [Related]
16. Trimetrexate inhibits progression of the murine 32Dp210 model of chronic myeloid leukemia in animals expressing drug-resistant dihydrofolate reductase.
Sweeney CL; Frandsen JL; Verfaillie CM; McIvor RS
Cancer Res; 2003 Mar; 63(6):1304-10. PubMed ID: 12649191
[TBL] [Abstract][Full Text] [Related]
17. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
18. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs.
Theti DS; Jackman AL
Clin Cancer Res; 2004 Feb; 10(3):1080-9. PubMed ID: 14871988
[TBL] [Abstract][Full Text] [Related]
19. In vivo selection of retrovirally transduced hematopoietic stem cells.
Allay JA; Persons DA; Galipeau J; Riberdy JM; Ashmun RA; Blakley RL; Sorrentino BP
Nat Med; 1998 Oct; 4(10):1136-43. PubMed ID: 9771746
[TBL] [Abstract][Full Text] [Related]
20. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
